Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy (PRAPT)
Primary Purpose
Gastric Cancer
Status
Terminated
Phase
Phase 3
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Laparoscopy-assisted gastrectomy
Sponsored by
About this trial
This is an interventional treatment trial for Gastric Cancer focused on measuring gastric cancer, proximal gastrectomy, total gastrectomy, laparoscopy, reflux esophagitis, double tract reconstruction
Eligibility Criteria
Inclusion Criteria:
- Age 20~80
- Informed consent
- No other malignancies
Proximal gastric cancer met by following conditions
- Lesion located on proximal stomach (upper one third)
- Lesion below 5cm in size
- Lesion confined to proper muscle depth (cT2)
- No evidence of metastatic enlarged LN on #5, 6, 4d, 10 basins and other distant metastasis. (cN1)
Exclusion Criteria:
- If patients is only suitable to total gastrectomy, he will be excluded.
Sites / Locations
- Seoul National University Bundang Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
LAPG
LATG
Arm Description
LAPG : laparoscopy-assisted proximal gastrectomy with double tract reconstruction group
LATG : laparoscopy-assisted total gastrectomy group
Outcomes
Primary Outcome Measures
Rate of reflux esophagitis
Comprehesive evaulation by 24hr pH monitoring, DISIDA scan, Endoscopic evaluation according to LA classification and Visick score
Rate of reflux esophagitis
Comprehesive evaulation by 24hr pH monitoring, DISIDA scan, Endoscopic evaluation according to LA classification and Visick score
Rate of reflux esophagitis
Comprehesive evaulation by 24hr pH monitoring, DISIDA scan, Endoscopic evaluation according to LA classification and Visick score
Secondary Outcome Measures
Full Information
NCT ID
NCT01433861
First Posted
September 10, 2011
Last Updated
January 6, 2017
Sponsor
Seoul National University Bundang Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01433861
Brief Title
Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy
Acronym
PRAPT
Official Title
Phase III Prospective Randomized Clinical Trial of Laparoscopy-assisted Proximal Gastrectomy (LAPG) and Laparoscopy-assisted Total Gastrectomy (LATG) for Upper Gastric Cancer. (Multicenter Study)
Study Type
Interventional
2. Study Status
Record Verification Date
January 2017
Overall Recruitment Status
Terminated
Why Stopped
We planed to study later
Study Start Date
July 2012 (undefined)
Primary Completion Date
November 2012 (Actual)
Study Completion Date
November 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Seoul National University Bundang Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The choice of surgical strategy for patients with proximal gastric cancer is controversial mainly because proximal gastrectomy is infamous for high rates of reflux symptoms and anastomotic stricture. but there are no prospective randomized trials until now.
The primary end point of this study is whether the rate of reflux esophagitis is different or not between LAPG and LATG. Through this study, we
Detailed Description
Prospective Randomized Clinical Trials between Laparoscopy-assisted Proximal Gastrectomy and Laparoscopy-assisted Total Gastrectomy.
LAPG reconstruction: double tract reconstruction (3 anastomosis, intracorporeal Roux-en Y esophago-jejunostomy, extracorporeal gastro-jejunostomy 10cm below esophago-jejunostomy,extracorporeal jejuno-jejunostomy 20cm below gastro-jejunostomy)
LATG reconstruction: intracorporeal Roux-en Y esophago-jejunostomy
Primary end point : incidence of reflux esophagitis after operation
Sample Size : LAPG 97 cases, LATG 97 cases (p1=0.018 p2=0.018, a=0.05, b=0.80) Non-inferiority test, non-inferior margin (delta) : 0.05. Sample size calculated by our MRCC(Medical Research Collaborating Center, http://mrcc.snubh.org)
Study duration : 48 months (enrollment 36months, follow-up 12months)
Reflux esophagitis evaluation methods
Ambulatory 24hr-pH esophageal holter monitoring for acid reflux
DISIDA scan for bile reflux
Endoscopic evaluation (Grading according to LA classification)
Visick score (subjective symptoms)
EORTC sto 22 and GIQLI evaluation (Quality of Life)
Nutritional Benefits (Body weight, Triceps Skin folds Thickness, Blood test)
Upper gastrointestinal study
Gastric emptying scan
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastric Cancer
Keywords
gastric cancer, proximal gastrectomy, total gastrectomy, laparoscopy, reflux esophagitis, double tract reconstruction
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
7 (Actual)
8. Arms, Groups, and Interventions
Arm Title
LAPG
Arm Type
Active Comparator
Arm Description
LAPG : laparoscopy-assisted proximal gastrectomy with double tract reconstruction group
Arm Title
LATG
Arm Type
Active Comparator
Arm Description
LATG : laparoscopy-assisted total gastrectomy group
Intervention Type
Procedure
Intervention Name(s)
Laparoscopy-assisted gastrectomy
Intervention Description
Laparoscopy-assisted proximal gastrectomy versus Laparoscopy-assisted total gastrectomy
Primary Outcome Measure Information:
Title
Rate of reflux esophagitis
Description
Comprehesive evaulation by 24hr pH monitoring, DISIDA scan, Endoscopic evaluation according to LA classification and Visick score
Time Frame
postoperative 3 month
Title
Rate of reflux esophagitis
Description
Comprehesive evaulation by 24hr pH monitoring, DISIDA scan, Endoscopic evaluation according to LA classification and Visick score
Time Frame
postoperative 6 month
Title
Rate of reflux esophagitis
Description
Comprehesive evaulation by 24hr pH monitoring, DISIDA scan, Endoscopic evaluation according to LA classification and Visick score
Time Frame
postoperative 12 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 20~80
Informed consent
No other malignancies
Proximal gastric cancer met by following conditions
Lesion located on proximal stomach (upper one third)
Lesion below 5cm in size
Lesion confined to proper muscle depth (cT2)
No evidence of metastatic enlarged LN on #5, 6, 4d, 10 basins and other distant metastasis. (cN1)
Exclusion Criteria:
If patients is only suitable to total gastrectomy, he will be excluded.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hyung-Ho Kim, M.D., Ph.D.
Organizational Affiliation
Seoul National University Bundang Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Seoul National University Bundang Hospital
City
Seongnam
State/Province
Gyenggi
Country
Korea, Republic of
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy
We'll reach out to this number within 24 hrs